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KAJIAN FITOKIMIA, BIOLOGIKAL, KESTABILAN DAN FARMAKOKINETIK 
EKSTRAK-EKSTRAK TIGA VARIASI DAUN  
Ficus deltoidea Jack  
 
ABSTRAK 
Kajian ini telah dijalankan bagi memberikan maklumat terhadap pemiawaian esktrak 
daun Ficus deltoidea (FD).  Tiga variasi pokok iaitu FD var. terengganuensis, FD 
var. angustifolia dan FD var. deltoidea telah dikaji. Kajian dibahagikan kepada lima 
bahagian iaitu penyiasatan kimia, pemprofilan kimia, pemprofilan biokimia, kajian 
stabiliti dan pemprofilan biologi. 
 
Lima sebatian telah diasingkan yang merangkumi tiga triterpenoid, β-amyrin 
sinamat, β-sitosterol dan friedelin dan dua flavonoid, viteksin dan isoviteksin. 
Pengecaman dan penjelasan struktur sebatian-sebatian ini dibangunkan melalui 
teknik spektroskopi. 
 
Ekstrak dianalisis untuk penentuan flavonoid total, polifenol, tanin, protein, 
polisakarida dan glikosaponin. Kandungan flavonoid total, polifenol dan tanin dalam 
ekstrak-ekstrak ini dalam julat  27.35 ± 1.08 sehingga 86.85 ± 0.58 (mg/g), 36.37 ± 
0.27 sehingga 172.78 ± 0.47 (mg/g) dan 96.32 ± 0.75 sehingga 942.15 ± 4.08 
(mg/g), masing-masing. Peratus protein, polisakarida dan glikosaponin total dalam 
ekstrak-ekstrak ini dalam julat 63.39 ± 0.26 sehingga 66.53 ± 2.74 (%), 0.01 ± 0.00 
sehingga 5.11 ± 0.17 (%) dan 7.44 ± 1.07 sehingga  35.21 ± 1.26 (%), masing-
masing. 
 
Pemprofilan kimia kualitatif dan kuantitatif melibatkan penggunaan UV, FTIR, 
HPTLC dan HPLC. Sistem HPLC cerunan (gradient) telah dibangunkan dan 
divalidasi menggunakan viteksin dan isoviteksin sebagai penanda dan telah 
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digunakan untuk kuantifikasi penanda tersebut dalam ekstrak metanol dan air. 
Kepekatan viteksin dalam ekstrak metanol dalam julat 4.95 sehingga 12.18 mg/g, 
sementara kepekatan viteksin dalam ekstrak air dalam julat 2.48 sehingga 19.05 
mg/g.  Kepekatan isoviteksin dalam ekstrak metanol dalam julat 1.58 sehingga 
41.49 mg/g, sementara kepekatan isoviteksin dalam ekstrak air dalam julat 3.61 
sehingga 26.94 mg/g. 
 
Kajian pemprofilan biokimia ekstrak daun diselidiki untuk penentuan aktiviti 
antioksidan, antihipertensi, anti-inflamasi dan antiangiogenik. Ekstrak berbagai 
varieti tumbuhan yang berbeza menunjukkan pelbagai aktiviti antioksidan pada 
pelbagai model antioksidan seperti penghapusan radikal bebas DPPH, 
penghapusan anion superoksida,  xantina oksidase (XOD), kuasa penurunan Fe (III) 
ke Fe (II), penghapusan nitrik oksida (NO) dan peroksidasi lipid. Kajian 
antihipertensi menggunakan asai enzim pengubah angiotensin (ACE) menunjukkan 
bahawa ekstrak mempunyai potensi sebagai agen antihipertensi.  Aktiviti 
antihipertensi ekstrak ditemui setanding dengan kaptopril, perencat ACE yang 
diketahui secara meluas.  Ekstrak menunjukkan variasi dalam aktiviti anti-inflamasi 
dalam pelbagai model seperti lipoksigenase (LOX), hialuronidase (HYAase) dan 
edema telinga dicetus TPA. Dalam kajian antiangiogenik, ekstrak FDLSPLSW dan 
penanda, viteksin dan isoviteksin menunjukkan aktiviti 100%. 
 
Dalam kajian kestabilan, ekstrak disimpan pada 4 keadaan simpanan yang berbeza 
selama enam bulan, dan sampel dianalisis dalam selang 1 bulan menggunakan 
FTIR dan HPLC.  Berdasarkan kajian, didapati sebatian penanda dalam ekstrak 
yang disimpan pada 25 ºC  adalah lebih stabil dari ekstrak yang disimpan pada 30 
ºC /65% RH,  40 °C /75% RH, 50 °C /85% RH and 60 °C /85% RH.  Selain itu, 
isoviteksin didapati lebih stabil dibandingkan dengan viteksin. Anggaran hayat 
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simpan (t90) dari viteksin dan isoviteksin adalah sekitar 1.5 dan 14 bulan, masing-
masing pada 25 º C. 
 
Dalam kajian farmakokinetik, ekstrak air FD. var. terengganuensis berlabel 
FDLSPLS diberikan secara oral dalam dos 500 mg/kg berat badan kepada tikus 
Sprague-Dawley. Sampel plasma, urin dan najis dianalisis dengan menggunakan 
kaedah HPLC cerunan, yang dibangunkan dan divalidasi menggunakan viteksin dan 
isoviteksin. Keputusan kajian menunjukkan bahawa kedua-dua penanda tidak dapat 
dikesan dalam sampel plasma, urin dan najis. 
 
Keputusan kajian menunjukkan bahawa kaedah HPLC yang dibangunkan boleh 
digunakan untuk pemiawaian ekstrak. Kedua-dua ekstrak telah menunjukkan 
potensi sebagai agen antioksida, anti-inflamasi dan antihipertensi. Sementara, 
ekstrak air FD  var. terengganuensis menunjukkan aktiviti antiangiogenik. 
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PHYTOCHEMICAL, BIOLOGICAL, STABILITY AND PHARMACOKINETIC 
STUDIES ON THE EXTRACTS OF THREE VARIETIES OF 
 Ficus deltoidea Jack. LEAVES  
 
ABSTRACT 
This study has been conducted to provide information on the standardization of 
extracts of Ficus deltoidea (FD) leaves.  Three plant varieties namely FD var. 
terengganuensis, FD var. angustifolia and FD var. deltoidea were studied. The study 
was divided into five parts: chemical investigation, chemical profiling, biochemical 
profiling, stability studies and biological profiling. 
 
Five compounds have been isolated that includes three triterpenoids, β-amyrin 
cinnamate, β-sitosterol and friedelin and two flavonoids, vitexin and isovitexin.  
Identification and structural elucidation of these compounds was established through 
spectroscopic techniques.   
 
The extracts were analysed for the determination of total flavonoids, polyphenols, 
tannins, protein, polysaccharides and glycosaponin.  The total flavonoids, 
polyphenols and tannins content in these extracts in range 27.35 ± 1.08 to 86.85 ± 
0.58 (mg/g), 36.37 ± 0.27 to 172.78 ± 0.47 (mg/g) and 96.32 ± 0.75 to 942.15 ± 4.08 
(mg/g), respectively.  The percentage of total proteins, polysaccharides and 
glycosaponins in these extracts in range 63.39 ± 0.26 to 66.53 ± 2.74 (%), 0.01 ± 
0.00 to 5.11 ± 0.17 (%) and 7.44 ± 1.07 to 35.21 ± 1.26 (%), respectively. 
 
The qualitative and quantitative chemical profiling involved the use of UV, FTIR, 
HPTLC and HPLC.   A gradient HPLC system has been developed and validated 
using vitexin and isovitexin as markers and was applied for the quantification of 
these markers in methanol and water extracts.  The concentration of vitexin in 
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methanol extracts in range 4.95 to 12.18 mg/g, whilst the concentration of vitexin in 
water extracts in range 2.48 to 19.05 mg/g.  The concentration of isovitexin in the 
methanol extracts in range 1.58 to 41.49 mg/g, while the concentration of isovitexin 
in the water extracts in range 3.61 to 26.94 mg/g.   
 
Biochemical profiling study of the leaves extracts were investigated for 
determination of antioxidant, antihypertensive, anti-inflammatory and antiangiogenic 
activities.  The extracts of different varieties of the plant displayed varying 
antioxidant activities in various antioxidant models such as DPPH free radical 
scavenging, superoxide anion scavenging, xanthine oxidase (XOD), reducing power 
of Fe(III) to Fe(II), nitric oxide (NO) scavenging and lipid peroxidation.  
Antihypertensive studies using angiotensin converting enzyme (ACE) assay showed 
that the extracts have potential as antihypertensive agents.  Antihypertensive 
activities of the extracts were found to be comparable to captopril, a widely known 
ACE inhibitor.  The extracts showed the variation in the anti-inflammatory activity in 
various models such as lipoxygenase (LOX), hyaluronidase (HYAase) and TPA-
induced ear oedema.  In antiangiogenic studies, FDLSPLSW extract and the 
markers, vitexin and isovitexin showed 100 % activity. 
 
In stability studies, the extracts were stored at 4 different storage conditions for six 
months, and samples were analysed at an interval of 1 month using FTIR and 
HPLC.  Based on the studies, it was found that marker compounds in the extracts 
stored at 25 ºC were more stable as compared to the extracts stored at 30 ºC /65% 
RH, 40 °C /75% RH, 50 °C /85% RH and 60 °C /85% RH. Moreover, isovitexin was 
found to be more stable as compared to vitexin.  Estimated shelf life (t90) of vitexin 
and isovitexin was approximately 1.5 and 14 month, respectively at 25 ºC. 
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In pharmacokinetic studies, water extracts of FD var. terengganuensis labelled 
FDLSPLS were administered orally in a dose of 500 mg / kg body weight to 
Sprague-Dawley rats.  The plasma, urine and feces samples were analysed using 
gradient HPLC method, which was developed and validated using vitexin and 
isovitexin.   Results of the study show that both the markers were not detected in 
plasma, urine and feces samples.  
 
Results of the study indicate that the developed HPLC methods can be applied for 
standardization of the extracts.  Both extracts have shown potential as an 
antioxidant, antiinflammatory and antihypertensive agent. Whilst, the water extract of 
FD var. terengganuensis show antiangiogenic activity.   
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CHAPTER ONE 
INTRODUCTION 
1.1 Introduction 
Medicinal plants have been used for thousands of years in virtually all cultures as 
sources of medicine.  Over recent years, the use of medicinal plants has grown 
significantly.  This is not only due to a general trend toward the use of natural 
products, but more towards available evidence regarding the safety and efficacy of 
herbal medicinal products.  In most of the European countries, submissions of 
quality, safety and therapeutic data is mandatory for authorization of herbal 
medicinal products.   Germany, France, Sweden, Denmark and Switzerland have 
also established specific national regulations on evaluation of herbal products.  
Other countries like Netherland, United Kingdom and Portugal regulate these 
products in the same way as ordinary pharmaceuticals (Busse, 2000).  
 
According to the World Health Organization (WHO), herbal medicines contain plant 
parts or plant material in the crude or processed state as active ingredients and may 
contain excipients.  Combinations with chemically defined active substances or 
isolated constituents are not considered herbal medicines (WHO Technical Report, 
1996).  Similarly, the European Medicinal Evaluation Agency (EMEA) defines herbal 
medicinal products as medicinal products containing exclusively herbal drugs or 
herbal drug preparations.   
 
Herbal drugs are plants or plant parts in an unprocessed state which are used for 
medicinal or pharmaceutical purpose.  Herbal drugs preparation are comminuted or 
powdered herbs, extracts, tinctures, fatty  or essential oils, expressed juices, 
processed resins or gums, and so forth prepared from herbal drugs, and 
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preparations whose production involves a fractionation, purification or concentration 
processes (EMEA, 1999).  
 
Herbs contain complicated mixture of organic chemicals which may include fatty 
acids, sterols, alkaloids, glycosides, saponins, tannins and terpenes.  The 
concentration of these substances depends on various factors related to the species 
variation, seedlings growing condition, processing and production of the herbal 
products.  
 
Herbal products may contain a single herb or combinations of several herbs 
believed to have complementary effects.  But it is usually difficult to determine which 
components are biologically active.  The chemical constituents in the herbs were 
affected by the processing activity and environmental factors that will contribute in 
their pharmacological effect and the uniformity of the herbal products.  To overcome 
this situation, manufacturers have attempted to create more consistent products 
through standardization using marker compounds, unique chemical constituents in 
the herbs and alter the production process to achieve consistent level of the markers 
in every batch.  
 
Herbal products are usually perceived as safe because they are natural.  However, 
many side effects have been reported from the use of herbal products (Bent and Ko, 
2004).  These include direct toxic effects and allergic reactions.  The information on 
safety and efficacy of herbs or plant medicine are limited in a number of ways such 
as data is year‟s old, limited in vitro and in vivo studies, drug interactions, effects in 
special populations and toxic reactions (O‟hara et al., 1998).  The Food and Drug 
Administration (FDA) has categorized about 250 herbs as “generally recognized 
safe” (GRAS) including chamomile, echinacea, feverfew, garlic, ginger, ginkgo and 
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ginseng; based on their long-term traditional use without significant side effects 
(O‟hara et al., 1998).   
 
For the purpose of lead discovery or for the scientific validation of a traditional 
medicinal plant or a phytopharmaceutical, active principles in the complex matrices 
need to be identified.  It is currently estimated at least 420,000 plants species exist 
in nature (Bramwell, 2002), less than 5% of the plants have been screened for one 
or more biological activities (Verpoorte et al., 2000).  More than 100,000 secondary 
metabolites are known though only a small percentage of all plant have been 
studied.  
 
It is estimated about 25% of all the modern medicines are directly or indirectly 
derived from higher plants.  For antitumor and antimicrobial drugs, about 60% of the 
medicines available in the market are derived from natural products, mainly from the 
higher plants (Farnsworth and Morris, 1976; de Smet, 1997; Cragg et al., 1998, Shu, 
1998; Calixto, 2000).  According to the World Health Organization, about 65-80% of 
the world‟s population which lives in developing countries depends on the medicinal 
plants for primary healthcare due to lack of access to modern medicine (Calixto, 
2000).  In developed countries such as Germany, France, Italy and the United 
States, herbal medicinal preparations are very popular and have been used 
traditionally for a longtime and there are guidelines for the registration of such 
medicines (Calixto, 2000). 
 
Based on the WHO and the EMEA quality guidelines (Table 1.1), the great efforts 
have to be made to ensure the quality of the herbal drugs.  To ensure a consistent 
quality of a therapeutic agent, it is evident that only suitable standardized and 
validated process should be used.  In addition, fingerprint, chromatograms and 
spectrograms analysis can also provide chemical information to help in 
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standardization.  This technique is more effective for comparing and evaluating 
quality control of herbal drugs (Ren, 2001 and Li et al., 2002 as cited by Chaudhary 
et al., 2007). 
 
Table 1.1: WHO Research Guidelines for Evaluating the Safety and Efficacy of 
Herbal Medicine (WHO, 1993) 
 To ensure the reliability and repeatability of research on herbal medicines, the 
identity and quality of the plant material or preparation must be determined. 
 A description should be provided of the physical and chemical tests done to 
identify the plant substances and a chromatogram of the active fraction or 
characterizing compound should be sufficient to identify a characteristic mixture of 
substances. 
 
1.2 Quality Control in the Standardization of Herbal Medicine 
Herbal medicines are formulated from a single or mixture of plants and have been 
used widely in treating a range of diseases.  However, as stated in the Calixto 
(2000), only few programs have been established to study the safety and efficacy of 
herbal medicines as originally proposed by the WHO guidelines for the assessment 
of herbal medicines.  Generally, herbal medicines are always assumed safe and 
free from side effects based on their traditional use.  Although this is not supported 
by scientific data, the situation leads to the tremendous growth in 
phytopharmaceutical usage as compared to synthetic drugs (Calixto, 2000). 
 
Many phytopharmaceuticals in the market are crude extracts and thus complex 
mixtures of compounds.  Investigation of pharmacological activity on single isolated 
compounds versus the original plant extracts exerts polyvalent pharmacological 
effects (Wagner, 2001).  This might explain the pharmacological synergistic effects 
and the phenomenon that very often an extract possesses a much better therapeutic 
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effect than single isolated constituent.  In consequence, the application of refined 
herbal extract rather than “isolated active principle(s)” may be favored in order to get 
benefit from the broad therapeutical and pharmacological action related to the 
special composition of the ingredients in the entire plant.   
 
Herbal medicinal products (HMPs) consist of hundreds of constituents and some of 
them may be very toxic such as digitalis, pyrrolizidine alkaloids, ephedrine and 
phorbol esters.  Establishing appropriate strategies for the analysis of quality, safety 
and efficacy, and the process of standardization of HMPs is a big challenge due to 
complex chemical composition.  With increasing knowledge and advances in 
analytical methods, standardized, safe and high quality HMPs can be manufactured 
successfully. 
 
In this study, Ficus deltoidea (FD) which is locally known as „mas cotek or secotek 
emas‟ has been selected.   It is one of the most popular medicinal plants after 
Tongkat Ali (Eurycoma longifolia Jack), Hempedu bumi (Andrographis paniculata), 
Misai Kucing (Orthosiphon stamineus), Kacip Fatimah (Labisia pumila) and pegaga 
(Centella asiatica) because of its traditional use in treating many disease including 
high blood pressure, improve blood circulation, diabetes, gout, pneumonia, heart 
problems, diarrhea and skin infection (Fasihudin and Hasmah, 1991).   
 
1.3 Research Objectives 
Although, a number of products manufactured from Ficus deltoidea are available in 
the market, there is still lack of information in terms of the chemical components, 
quality, safety and efficacy of the plant.  Since, the plant being one of the popular 
herbs used in Malay traditional medicine, the pharmacological properties of the plant 
have not been studied yet.   
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Objectives of the study are:  
1. To identify chemical constituents of FD leaves in order to develop and 
validate a reliable analytical method for chemical profiling and 
standardization of FD leaves extracts.  
2. To evaluate FD leaves extracts for in vitro biological activities such as 
antioxidant, anti-inflammatory, antihypertensive and antiangiogenesis. 
3. To investigate the FD leaves extracts for accelerated stability. 
4. To investigate the pharmacokinetics of selected FD leaves extracts in rats. 
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CHAPTER TWO 
TAXONOMIC CLASSIFICATION AND LITERATURE REVIEW 
2.1 Taxonomic Classification 
Taxonomically, this plant is classified as the following scheme: 
Family   : Moraceae 
Genus   : Ficus 
Species  : deltoidea 
Scientific name : Ficus deltoidea Jack  
Synonyms  : Ficus diversifolia Blume 
 
2.1.1 Vernacular Name  
In Peninsular Malaysia, East Malaysia and Kalimantan, this plant is known as mas 
cotek, secotek emas, telinga kera, sempit-sempit and agoluran.  In Indonesia, it is 
known as tabat barito, ara jelatih, ara tunggal, api-api telinga gajah and api-api-
telinga kera and in Africa, kangkalibang.   
 
2.1.2 Nomenclature 
The common name of this plant comes from the habit of as epiphytes on larger 
trees.  The scientific name, deltoidea or triangularis refers to the shape of the 
leaves.  Same is in Malaysia, the local name of this plant referred to the golden dot 
(emas or mas) which can be observed on the upper layer of the leaves.  Also the 
shape of the leaves was slightly same as the ear of monkey or ‘beruk or kera’ in 
Malay.   
 
2.1.3 Moraceae 
According to the Bhattacharya and Johri (1998) in their book title Flowering Plants; 
Taxonomy and Phylogeny, the family of Moraceae consists of 53 genera and 1400 
species, distributed in tropical and subtropical zones of the world (Africa, Asia and 
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America).  They also have stated that genus Ficus has more than 1000 species and 
their statement has been proved by Wagner et al. (1999) as cited by Starr et al. 
(2003).    
 
The genus Ficus occupies many habitats from lowland swamps to mountain 
rainforest and semi-arid areas.  They have a wide range of life forms from lianescent 
climbers to hemiepiphytes and forest canopy trees.   
 
2.1.4 Plant Description 
Ficus deltoidea (FD) Jack is evergreen shrub or small tree up to 2 m tall, usually 
bushy and sometimes epiphytic.  Leaves of this species are broadly spoon-shaped 
to obovate, blade thinly to thickly leathery, 2-8 x 1.5-7.5 cm, bright green above and 
rust-red to olive brown beneath.  The underside of the leaf showed midrib forked or 
not but generally there is a black spot (gland) at the fork and on the upper side of 
the leaves, yellow spot can be observed all over the surface. 
 
 The shapes of the leaf are more variable in the whole genus and ranges from 
elliptical or spathulate-shaped, the apex is blunt, truncate or widely notched and 
rarely pointed. The leaves are also succulent.  Shapes of the figs also vary from one 
another, from spherical to round: peduncle 3-15 x 1-2 mm: basal bract ca. 1 mm: 
body 5-7 mm wide and with 1.5 cm across.  Figs are freely produced in pairs and 
ripening from dull yellow and then to orange or red.  This plant is native to South 
East Asia, Borneo and Philippines (Brickell and Zuk, 1997 cited by Starr et al. 2003).  
Riffle (1998) cited by Starr et al. (2003) described this specie as indigenous to the 
Southern Philippines southward and westward to South East Asia, Malaysia and 
Indonesia.   
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According to the Malaysian traditional herbalist, at least 7 different varieties are 
identified, which are FD var. motleyana, FD var. angustifolia, FD var. intermedia, FD 
var. kunstleri, FD var. deltoidea , FD var. bilobata and FD var. terengganuensis 
(Kamarudin and Latiff, 2002).  Other varieties also have been identified by Corner, 
1965 and 1969; FD var. angustissima, FD var. arenaria, FD var. bilobata, FD var. 
borneensis, FD var. kinabaluensis, FD var. lutescens, FD var. oligoneura and FD 
var. peltata.   
 
For the purpose of analytical study, three varieties have been selected which are FD 
var. angustifolia, FD var. terengganuensis and FD var. deltoidea because availability 
of species during the study conducted (Figure 2.1). 
 
2.1.4 (a) FD var. terengganuensis (Corner, 1969) 
Distribution:  Malaya (Terengganu, east coast of Pahang) 
Ecology:  Coastal shrub and in Leptospermum forest at 1300 m altitude, also 
epiphytic in lowland forest. 
Morphology:  Lamina size from 2.3 x 1.8 – 5.5 cm, elliptic to rounded-obovate or 
some what bilobed: midrib dichotomous about 1/2-2/3 lamina; glands 3-4 (-5), two 
basal, the others at the dichotomies of the main veins: petiole 10-50 x 1-2 mm.  Fig-
body 9-12 mm wide, rose-red to purple-black when ripening: peduncle 6-20 x 1.5 
mm:  basal bracts 1-1.5 mm.  Twigs are 2 mm thick.   
 
2.1.4 (b) FD var. angustifolia (Corner, 1969) 
Distrbution: Lower Thailand, Malaya, Riau Archipelago, Sumatra, Borneo, Anamba 
and Natuna Island, Palawan.   
Ecology:  Epiphytic in lowland and mountain forest up to 1500 m altitude and 
common on seashores 
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Morphology:  A shrub, growing up to 4 m high.  Shapes of this varieties are 
spathulate or lanceolate obovate, rarely obscure lobed at the apex and sizes from 2-
7 cm x 0.8-3 cm.  There also a midrib dichotomous at or above the middle of the 
leaf.  At the lower part, one gland can be seen at the fork of the midrib.  Fig ripening 
yellow to orange or red: peduncle 5-15 x 1 mm, slender: body 6-8 x 4-6 mm.   
 
2.1.4 (c) FD var. deltoidea (Corner, 1969) 
Distribution: Malaya (Singapore, East Johore, South East Pahang), Riouw and 
Lingga Archipelagos, Bangka, Sumatra, Borneo. 
Ecology:  Generally epiphytic in lowland and mountain forest, up to 1200 m altitude 
(Kinabalu), also terrestrial on rocks and sea-shores. 
Morphology:  A small shrub with smaller figs ripening orange to red.  The leaves are 
lanceolate and penniveined.  A strong distinction of this plant is rugose-angular 
ovary.   
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Ficus deltoidea var. terengganuensis 
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Ficus deltoidea var. angustifolia 
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Ficus deltoidea var. deltoidea 
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Figure 2.1: Pictures of the plants  
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2.1.5 Traditional Uses 
In Malaysia, decoction of the Ficus deltoidea leaves is used to improve blood 
circulation and regain body strength and for treating diabetes, high blood pressure, 
heart problems, gout, diarrhea, pneumonia and skin infection.  Some communities in 
Sabah consume the plant leaves as herbal tea for anti aging and youthful 
appearance (Fasihudin and Hasmah, 1991). 
 
There are many claims by the traditional medicine practitioners regarding this plant 
in Malaysia.  Unfortunately, there is no scientific study on this plant to prove these 
claims.  Therefore, leaves of this plant were selected in this study to provide 
information to the herbal industry in Malaysia so that they can produce high quality 
products. 
 
2.2 Literature Review  
Until now only two report of blood glucose lowering effect and antinociceptive effect 
of Ficus deltoidea have been published (Sulaiman et al., 2004; Sulaiman et al., 
2008).  Phytochemical screening detected the presence of different classes of 
constituents, such as flavonoids, saponins, steroids, terpenes and tannins 
(Sulaiman et al., 2008).  Therefore, the studies have been conducted to give the 
information on the safety, quality and efficacy aspects of Ficus deltoidea leaves. 
 
The traditional uses and scientific studies on genus Ficus are given in Table 2.1 and 
Table 2.2, respectively.  From the aerial part of genus Ficus various chemical 
constituents including phenolics, triterpenoids, sterols, flavonoids and alkaloids has 
been identified.  Reviews on the chemicals isolated from genus of Ficus are 
summarized in Table 2.3. 
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2.2.1 Traditional Uses of the Genus of Ficus 
Table 2.1:  Traditional uses of the genus of Ficus 
Ficus spp.  Traditional uses References  
Ficus 
platyphylla  
 
 In Northern Nigeria, this plants is used for 
treating several diseases including insomnia, 
psychorosis, depression and also used as an 
analgesic 
Audu (1989) as 
cited by Chindo et 
al., 2003. 
 
Ficus 
racemosa 
(Ficus 
glomerata) 
 In India the leaves of this species has been 
used for treating dysentery, bilious affection 
and also used as a mouth wash in spongy 
gum.   
 The roots, fruits and bark are used for treating 
dysentery and diabetes.   
 The fruits are also used to relieve diarrhoea  
 In Bombay, this plant is a popular remedy for 
mumps and other inflammatory enlargement 
and the milky juice is popular among 
traditional healers as an antiinflammatory 
remedy. 
 Also reports for treatment of skeletal fracture 
 The roots are used as medicine against 
hydrophobia.  Its fruits are effective against 
leprosy, diseases of the blood, fatigue, 
bleeding nose and cough.  Its bark used for 
asthma and its leaves for bronchitis.  It is also 
used as carminative, astringent, vermifuge 
and anti-dysentery drug.  The plant also used 
to relieve inflammation of skin wounds, 
lymphadenitis, sprains and fibrositis. 
Mandal et. al, 
2000a; 
Kirtikar and Basu, 
1975; 
Nadkarni et al., 
1996; 
Chopra et al., 
1985; 
Ekanayake 
(1980) as cited by 
Mandal et al., 
2000a 
 
Mandal et al., 
2000b 
 
Ficus hispida  Various parts of this plant are used in Indian 
traditional medicine for the treatment of 
various ailments.  Bark was used as emetic 
and anti-diarrhoeal.  Fruits used as tonic, 
lactogogue, cooling, astringent and in hepatic 
obstruction. 
 The plant was found to be used widely as an 
anti-diarrhoeal, hepatoprotective, antitussive, 
antipyretic, anti-inlammatory, depurative, 
vulnerary, hemostatic, anti-ulcer and in 
treatment of anemia.   
 In West Bengal, India, people of Khatra used 
the leaves of this plant to cure diarrhoea. 
Kirtikar and Basu, 
1956; 
Nadkarni, 1976; 
Rastogi and 
Mehrotra, 1993; 
Peraza-Sanchez 
et al., 2002; 
Anon (1956) and 
Anon (1986) as 
cited by Mandal 
and Ashok 
Kumar, 2002 
 
 
Ficus 
bengalensis 
 Leaves of this plant are good for treating 
ulcers and leprosy.  The bark is astringent 
and useful in the treatment of dysentery, 
diarrhoea and diabetes. An infusion of the 
young buds also used for the treatment of 
diarrhoea and dysentery.  The young tips of 
hanging roots are given for obstinate 
vomiting.  The milky juice is externally applied 
for pains and bruises and as an anodyne in 
rheumatism, lumbago and also used as 
Satyati et al., 
1976; 
Hosamani and 
Pattanashettar, 
2003 
Kirtikar and Basu, 
1933 
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remedy for toothache.    
 The seeds and fruits are used for cooling and 
as tonic 
Ficus carica  Used for prevention of nutritional anaemia 
and an anthelmintic 
 Various parts of this plants used by the native 
of India as a diuretic, demulcent, emollient 
and as an anthelmintic 
 Fruits of this plant if taken internally along 
with senna and carminative herbs can gave 
mildly laxative properties 
Saeed and Sabir, 
2002; 
Sastri, 1976; 
Jaffe, 1943 
 
Omar et al., 2004 
Ficus sur  People of Zulu in Africa drink a decoction of 
the root and bark for pulmonary tuberculosis, 
an infusion of the leaf and bark used to 
improve milk production in cattle.   
 Tanganyika’s people used a decoction of bark 
as galactogogue in women and cows and to 
prevent vomiting. 
 In West Africa, the plant is used by traditional 
eye doctors.   
 In Zaire, the latex used for the treatment of 
burns.   
 In northern part of Nigeria, fresh young aerial 
root with the inner bark is chewed with 
kolanut to alleviate thirst and to treat throat.  
The leaves are claimed to act as a remedy for 
pectic ulcer.   
Watt and Breyer, 
1962 
 
 
Burkill, 1985 
 
 
 
 
 
 
Kunle et al., 1999 
Ficus septica  In Papua New Guinea, leaf of this plant is 
used to cure colds, fever, fungal and bacterial 
diseases. 
Baumgartner et 
al., 1990 
Ficus 
maxima 
 In folk medicine this plant has been used as 
anthelminthic and anti-rheumatic, anti-
anaemic and antipyretic agents.  
Diaz et al., 1997 
Ficus pumila  The leaves of the plant has been traditionally 
consumed by some Okinawan elders in 
Japan either as a beverage or used as an 
invaluable medicinal herb by the folks to treat 
diabetes, dizziness, high blood pressure, and 
neuralgia. There is evidence that some of the 
compounds in the plants regularly consumed 
by the Okinawans have powerful antioxidant 
and positive hormonal effects  
Mitsuhashi, 1988; 
Tobinaga, 1989 
and Nakatani, 
1992 as cited by 
Abraham et al., 
2008. 
Ficus 
insipida 
 The latex leaves and unripe fruits of this 
species have been used by the natives in 
Central America to Argentina in treatment of 
worm diseases. 
 Used as an anti-anaemic and anti-pyretic 
Peckolt (1942) as 
cited by Amorin et 
al., 1999; Lopes 
et al., 1993; 
Diaz et al., 1997 
Ficus 
beecheyana 
 This plant was widely distributed in east of 
Asia, especially in mainland China, Hong 
Kong, Vietnam and Taiwan.  Its rhizomes 
have been used in folk medicine to the 
treatment of rheumatism and diabetes and as 
carminative.   
 
Lee et al., 2002 
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Ficus 
fistulosa 
 In Central and South America the latex of 
some Ficus species has been traditionally 
used as vermifuge 
Hansson et al., 
1986 
Ficus 
asperifolia 
 The bark infusion of Ficus asperifolia is used 
for washing sores and ulcers and applied to 
circumcision wounds  In Ghana, the rough 
leaves are used for scraping patches of 
ringworm before further treatment  
Irvine,1961; 
Abbiw, 1990 
Ficus 
chlamydocar-
pa and Ficus 
cordata 
 In Cameroon, both plant were used in the 
treatment of filaris, diarrhoeal infections and 
tuberculosis. The decoction from the mixture 
(1:1 w/w) of root bark from Ficus 
chlamydocarpa and stem bark of Ficus 
cordata are used in the treatment of oral 
infections. 
Khabe (2007) as 
cited by Kuete et 
al., 2008 
Latex of 
some Ficus 
species  
 Latex has been traditionally used as 
vermifuge in Central and South America 
 Some Brazilian species (Ficus glabrata HBK, 
Ficus doliaria Martius, Ficus anthelmintica 
Martius and Ficus radula Humboldt and 
Bonpland), were introduced into medical 
practice as a powerful  vermifuge 
 The latex has been identified as active 
fraction of protein and namely ficin from the 
studied done on the Ficus laurifolia.   
Hansson et al., 
1986; 
Peckolt, 1942 as 
cited by Amorin et 
al., 1999 
 
 
 
Robbins, 1930 
Other 
species 
 The stem bark of Ficus vallis-chaudae used 
for the treatment of heart problems 
 Leaves of Ficus thonnigii used for 
rheumatism 
Kone et al., 2004 
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2.2.2 Scientific Study on the Genus of Ficus  
Table 2.2:  Scientific study on the genus of Ficus 
Ficus spp.  Bioactivities study References  
Ficus 
platyphylla  
 
 Studies has been showed this plant possesses 
antinociceptive, anti-inflammatory and 
gastrointestinal activities in rodents 
 Phytochemical analysis revealed the presence of 
flavonoids, tannins and saponins. 
 Chindo et al have been evaluated the central 
nervous system (CNS) activity using methanolic 
extract.  Results from the studies suggest the 
extract from stem bark contain psychoactive 
principles that are sedative in nature with possible 
neuroleptic properties 
Amos et al., 
2001 and 2002 
 
Amos et al., 
2001 
Chindo et al., 
2003 
Ficus 
racemosa 
 
 Evaluation on anti-inflammatory on carrageenin, 
serotonin, histamine and dextran-induced rat hind 
paw oedema models.  Results possessed of 
significant anti-inflammatory activity. 
 Studied on hypoglycaemic and antidiarrhoeal have 
been reported by Mandal et al. (1997a and 1997b) 
on leaves 
 The methanol extract of stem bark possesses 
significant antipyretic effect in the reduction of 
normal body temperature and yeast-provoked 
elevated temperature. 
 The extract of fruit is used in diabetes and 
leucoderma.  The alcoholic extract of the stem bark 
of the plant possessed antiprotozoal activity 
against Entamoeba histolytica.  It is also used in 
the treatment of mumps, smallpox, heamaturia and 
inflammatory conditions. 
 Studies done by Khan and Sultana have resulted 
that the extract from this plant is a potent 
chemopreventive agents and inhibits Fe-NTA 
induced renal carcinogenesis and oxidative 
damage response in Wistar rats. 
Mandal et al., 
2000a 
 
 
Mandal et al., 
1997a and 
1997b 
Rao et al., 
2002 
 
 
 
Mandal et al., 
2000b 
 
 
 
 
Khan and 
Sultana, 2005 
Ficus 
hispida 
 Studies done by Mandal and Ashok Kumar have 
been exhibited that methanolic extract of the leaf 
showed a significant results on the anti-diarrhoeal 
activity. 
 The chloroform extract of the leaves and twids 
showed significant cytotoxic activity against the 
lung and colon human cancer cell lines. 
Mandal and 
Ashok Kumar, 
2002 
 
Peraza-
Sanchez et al., 
2002                           
Ficus 
bengalensis 
 A water extract of the bark of this plant has been 
shown to possesses hypoglycemic, 
hypocholesterolaemic and hypolipidaemic effects  
 Two compounds isolated from ethanolic extract of 
the bark on this plant have shown antioxidant 
properties. 
 An antioxidant effect of aqueous extract of the bark 
has been evaluated in hypercholesterolaemic 
rabbits.  Results showed the extract has significant 
antioxidant effect  
Shroti and 
Aiman, 1960; 
Vohra and 
Parasar, 1970; 
Shukla et al. 
1994 and 1995 
Daniel et al., 
1998 ; 
Shukla et al., 
2004 
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 A glucoside isolated from the bark showed more 
potent hypoglycemic action as compared to crude 
ethanolic extract and activity was half of 
tolbutamide  
 Oral administration of bark extract showed 
significant antihyperglycemic effects in    diabetic 
rats by raising serum insulin levels or inhibiting 
insulinase activity in liver and kidney. 
Augusti, 1975 
 
 
 
Achrekar et al., 
1991 
 
 Ficus 
carica 
 A study hypoglaemic action of an oral fig-leaf 
decoctions in type-I diabetic patients by Serraclara 
et al. (1998) showed the total insulin doses given 
to the patients decreased during the study 
according to their glycemic profiles. 
 Investigation on methanolic extracts and five 
compounds isolated from the leaves exhibited 
irritant potential on mice ears. 
 In Amorin et al. (1999), the latex from this species 
showed of high toxicity and low anthelmintic 
efficacy and not recommended for the treatment of 
intestinal helminthiasis as claimed by the 
practitioner traditional medicine.   
Serraclara et 
al., 1998 
 
 
 
Saeed and 
Sabir, 2002 
 
Amorin et al., 
1999  
Ficus sur  Studied done by Kunle et al. resulted that hexane, 
methanol and water extracts showed antiulcer 
activity and spasmolytic effects.  Hot water extract 
was most effective compare to others.  
Furthermore all extracts except hexane extract was 
found t have gastroprotective activity. 
Kunle et al., 
1999 
Ficus 
septica 
 The methanolic extracts of the leaves showed an 
intense antibacterial and antifungal activity using 
TLC bioautographic assays against Penicillium 
oxalicum, Bacillus subtilis, Micrococcus luteus and 
Escherhia coli. 
Baumgartner 
et al., 1990 
Ficus 
fistulosa 
 Studies on methanol extract on bark and leaves 
exhibited of antiplasmodial activity 
 Studies done by Zheng et al. 2002, has 
successfully isolated a trichothecenes compound 
namely verrucarin L-acetate and found to have 
antimalarial activity against Plasmodium 
falciparum. 
Tuyen  et al., 
1998 
 
Zhang et al., 
2002  
Ficus 
sycomorus 
 An aqueous extract of stem bark of this plant can 
be used as analgesic to human and animals.  
Furthermore the extract also used for the treatment 
of ailments such as mental illness, wound dressing 
and diarrhoea.   
 Studies done by Sandabe et al. (2003) shown this 
plant has sedative and anticonvulsant effects on 
rats.  
 In Sandabe (2002), LD50 value gives 720mg/kg 
indicated of low toxicity and the extract also found 
to have partial or no inhibition on bacterial growth.  
 In Sandabe (2006), the extract of this plant shown 
the inhibitory effects on muscular activity (smooth 
and skeletal muscle) 
Sandabe and 
Kwari, 2000; 
Sandabe et al., 
2003 and  
Sandabe, 
2002 as cited 
by Sandabe et 
al., 2006. 
 
 
 
Sandabe et al., 
2006. 
Ficus  Studied done by Amorin et al. (1999) show the Amorin et al., 
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insipida high degree of toxicity and the low anthelmintic 
efficacy of the latex from this species.  Therefore 
the use of the products containing this latex in 
traditional medicine for the treatment of intestinal 
helminthiasis is not recommended. 
1999 
Ficus 
microcarpa 
 Methanol extract of bark have showed of 
antiplatelet activity. 
 Ao et al, 2008 reveal that the methanol extracts 
from bark, fruits and leaves of F. microcarpa 
contained high amounts of phenolic compounds 
and showed strong antioxidant and antibacterial 
effects. 
Li and Kuo, 
1997 
Ao et al., 2008  
Ficus  
benjamina 
 The methanolic extract of the leaves showed 
significant anti-inflammatory, antinociceptive and 
antipyretic activities. 
Farag, 2005 as 
cited by Simo 
et al., 2008 
Ficus 
hispida and 
Ficus carica 
 Anthelmintic study on the latex of these species in 
NIH mice naturally nfected with the oxyurids 
Syphacia obvelata and Aspiculuris tetraptera and 
cestode Vampirolepis nana showed the low 
anthelmintic efficacy plus the latex show high 
degree on toxicity.  So the latex is not 
recommended to use in the traditional medicine as 
claimed. 
 Study indicates that the ethanolic aqueous extract 
of dried ripe fruits of Ficus carica possesses an 
antiplatelet and spasmolytic effect.  The 
spasmolytic effect was mediated possibly through 
K+ ATP channel activation, which explain some of its 
medicinal uses in hyperactive gut disorders. 
Amorin et al., 
1999 
 
 
 
 
 
 
Gilani et al., 
2008. 
Ficus 
asperifolia 
 Water extract showed a significant dose-
dependent effect on the growth of human dermal 
fibroblast (142BR) at concentration of 50g/ml with 
38% growth. Above 50g/ml doses, extract showed 
cytotoxicity effect.  At high concentration of the 
infusion of the plant, the new cells will be 
proliferating.  Investigation for the effects of 
hydrogen peroxide induced damage on the 
fibroblast cell using same extract showed 58% 
protection against oxidative damage to the 
fibroblast cells. 
Annan and 
Houghton, 
2008 
Ficus 
chlamydoca
rpa and 
Ficus 
cordata 
 Methanol crude extracts and isolated flavonoids 
and isoflavonoids from both plants were evaluated 
for the antibacterial and anticandidal activities.  
Both extracts and compounds tested showed 
antimicrobial activity with crude extract from Ficus 
cordata are more active on the tested 
mycobacteria than that of Ficus chlamydocarpa. 
Kuete et al., 
2008 
Other 
species 
 Screening on the leaves of Ficus thonnigii showed 
antibacterial activity. 
 An aqueous extract of Ficus polita showed 
effective inhibition on HIV-1 and HIV-2 replication. 
 In the experiments using the latex of Ficus 
laurifolia Lamarck suggested that the active 
fraction was possibly a protein, called ficin. 
Kone et al., 
2004 
Ayisi and 
Nyadedzor, 
2003 
Robbins, 1930 
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2.2.3 Chemical Constituents from Genus of Ficus 
Table 2.3: Chemical constituents from genus of Ficus 
Ficus spp.  Chemical constituents References  
Ficus 
aripuanensis 
β-amyrin (1), α-amyrin (2), β-amyrin acetate 
(3), Germanicol (4), Lupeol (5) 
Sitosterol glycoside (6), Aripuanin (7)  
Nascimento et al., 
1999 
Ficus septica Ficuseptine (8), Antofine (9)  
 
Herbert and Moody, 
1972; Baumgartner et 
al., 1990 
Ficus 
pachyrachis 
(-)-Reticuline (10), (+)-Nor-reticuline (11)  Khan et al., 1992 
Ficus carica Bauerenol (12), Calotropenyl acetate (13), 
Lupeol acetate (14), Methyl maslinate (15), 
Oleanolic acid (16), Ψ-taraxasterol (17), 
Cadelene (18), β-amyrin (1), Lupeol (5), Rutin 
(19), 24-methylenecycloartanol (20) 
Ahmad and Abdul 
Malik 1988; Saeed 
and Sabir, 2002; Abu 
Mustafa et al., 1964; 
Subramaniam and 
Nair, 1970; El-Kholy 
and Shaban, 1966; 
Ahmad and Abdul 
Malik, 1988 
Ficus 
maxima 
5,7,3’,4’,5’-pentamethoxyflavone (21), 
5,6,7,5’-tetramethoxy-3’,4’-
methylenedioxyflavone (22), 5,6,7,3’,4’,5’-
hexamethoxyflavone (23), 5,6,7,3’,5-
pentamethoxy-4’-prenyloxyflavone (24)  
Diaz et al., 1997 
Ficus pumila Bergapten (25), β-sitosterol (26), α-amyrin 
(1), Taraxasterol (17), 11α-hydroxy-β-amyrin 
(27), Scopoletin (28) 
7,4’-dimethoxy-5-hydroxyisoflavone (29), 
Genistein (30), 5,7,2’,5’-tetrahydoxyflavanone 
(31), Naringenin (32), Hesperitin (33) , 
Apigenin (34) 
Taxifolin (35), Tricetin (36), Luteolin (37), 
Chrysin (38), Rutin (19), Isorhamnetin-3-O-
glucoside (39), Oxypeucedanin hydrate (40), 
Astragalin (41), Isoquercitrin (42), Apigenin 6-
C-α-L-rhamnopyranosyl-(1—2)-β—D-
glucopyranoside (43), Kaempferol 3-O-α-L-
rhamnopyranosyl (1—6)-β-D- 
glucopyranoside (44), Kaempferol 3-O-α-L-
rhamnopyranosyl (1—6)-β-D-
galactopyranoside (45) 
Juan et al., 1997, 
Pistelli et al., 2000, 
Kitajama et al., 1998a 
and 1998b, Abraham 
et al., 2008  
Ficus 
altissisma 
Demethyl-meliternin (46), Scutellarein 
tetramethyl ether (47), Quercetagetin-
3,6,7,3',4'-pentmethyl ether (48), Myricetin 
hexamethyl ether (49), Demethyl-melibentin 
(50), Hypolaetin pentamethyl ether (51) 
Mohamed et al., 2000 
Ficus 
bengalensis 
Rutin (19), Quercetin 3-galactoside (52), Ψ-
taraxasteryl ester (53) 
 
Studies on the fatty acids in seed oil of Ficus 
bengalensis was found to contain: 
Vernolic acid (54), Malvalic acid (55), 
Subramaniam and 
Nair,1970 
 
Subramaniam and 
Nair, 1970 
Hosamani and 
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Sterculic acid (56), Lauric acid (57), Myristic 
acid (58), Palmitic cid (59), Stearic acid (60), 
Oleic acid (61), Linoleic acid (62), Linolenic 
acid (63) 
Pattanashettar, 2003 
 
Ficus 
fistulosa 
3b-acetyl22,23,24,25,26,27-
hexanordamaran-20-one (64), 24-
methylenecycloartenol (65), Sorghumol 
(isoarbinol) (66), 11a,12a-oxidotaraxeryl 
acetate (67), Ursa-9(11):12-dien-3b-ol-
acetate (68), 3b-acetyl ursa-14:15-en-16-one 
(69), Lanosterol-11-one acetate (70), 
Verrucarin L acetate (71) 
Tuyen et al., 1998; 
Zhang et al., 2002 
Ficus 
microcarpa  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ficuisoflavone (72), Isolupinisoflavone E (73), 
Ficusic acid (74), Methyl-4'-hydroxy-3'-
methoxytropate (ficusol) (75), Ficuglucoside 
(76), 20-taraxastene-3β,22α-diol (77), 3β-
acetoxy-20-taraxasten-22α-ol (78), 3β-
acetoxy-22α-methoxy-20-taraxastene (79), 
3β-acetoxy-20 α,21α -epoxytaraxastane-22α-
ol (80), 3β-acetoxy-20α,21α-
epoxytaraxastane (81), 3β-acetoxy-19α-
methoxy-20-taraxastene (82), 3β-acetoxy-
19α-hydroperoxy-20-taraxastene (83), 3β-
acetoxy-12β,13β-epoxy-11α-
hydroperoxyursane (84), 3β-acetoxy-11α-
hydroperoxy-13αH-ursan-12-one (85), 3β-
acetoxy-1β,11α-epidioxy-12-ursene (86), 
(20S)-3β-acetoxylupan-29-oic acid (87), 
(20S)-3β-acetoxy-20-hydroperoxy-30-
norlupane (88), 3β-acetoxy-18α-hydroperoxy-
12-oleanen-11-one (89), 3β-acetoxy-12-
oleanen-11-one (90), 3β-acetoxy-12,19-
dioxo-13(18)-oleanene (91), 3β-acetoxy-
19(29)-taraxastene-20α–ol (92), 3β-acetoxy-
21α,22α-epoxytaraxastan-20α-ol (93), 3,22-
dioxo-20-taraxastene (94), 3β-acetoxy-
11α,12α-epoxy-16-oxo-14-taraxerene (95), 
3β-acetoxy-11α,12α-epoxy-14-taraxerene 
(96), 3β-acetoxy-25-methoxylanosta-8,23-
diene (97), 3β-acetoxy-25-hydroxylanosta-
8,23-diene (98), Acetylbetulinic acid (99), 
Betulonic acid (100), Acetylursolic acid (101) 
Ursonic acid (102), Ursolic acid (103) 
3-oxofriedelan-28-oic acid (104), Oleanonic 
acid (105), α-tocospiro A (106), α-tocospiro B 
(107), α-tocopherol (108), 27-nor-3β-hydroxy-
25-oxocyloartane (109), (22E)-25,26,27-
trinor-3β-hydroxycycloart-22-en-24-al (110), 
3β-acetoxy-5α-hydroxy-13,27-cyclours-11-
ene (111), 3β-acetoxy-2α-formyloxy-13,27-
cycloursan-11α-ol (112) 
Li and Kuo, 1997; Li 
and Kuo, 1998; 
Chiang and Kuo, 
2000; Chiang and 
Kuo, 2001; Chiang et 
al., 2005; Chiang and 
Kuo, 2003; Chiang et 
al., 2001 
 
 
 
 
 
Ficus insipida Moretenolactone (113) Lopes et al., 1993 
Ficus 
pantoniana 
Ficine (114), Isoficine (115) John and Russel 
(1965) 
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Ficus hispida Ficustriol (116), o-methyltylophorinidine (117) Peraza-sanchez et al., 
2002 
Ficus 
beecheyana 
Threo-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-
ethoxyprpan-1-ol (118), Erythro-2,3-bis(4-
hydroxy-3-methoxyphenyl)-3-ethoxypropan-
1-ol (119), Erythro-2,3-bis(4-acetoxy-3-
methoxyphenyl)-3-ethoxypropan-1-ol acetate 
(120), trans-4,5-bis(4-hydroxy-3-
methoxyphenyl)-1,3-dioxacyclohexane (121), 
trans-4,5-bis(4-acetocy-3-methoxyphenyl)-
1,3-dioxacyclohexane (122), Threo-3-(4-
hydroxy-3,5-dimethoxyphenyl)-3-
ethoxypropane-1,2-diol (123), 2,3-dihydroxy-
1-(4-hydroxy-3,5-diemthoxyphenyl)-1-
propanone (124), 3-hydroxy-1-(4-hydroxy-
3,5-dimethoxyphenyl)-1-propanone (125) 
Lee et al., 2002 
Ficus 
infectoria 
Luteolin 6-O-β-D-glycopyranoside 3’-O-α-L-
rhamnoside (126) 
Neeru et al., 1990 
Ficus 
chlamydo-
carpa  
β-amyrin (1), luteolin (37), alpinium isoflavone 
(127), genistein (30), laburnetin (128), β-
sitosterol-3-O-β-D-glucopyranoside (129) 
Kuete et al., 2008 
Ficus  
cordata 
 
β-amyrin (1), catechin (130), epiafzelechin 
(131), β-sitosterol-3-O-β-D-glucopyranoside 
(129) 
Kuete et al., 2008 
Fcus  
benjamina 
Β-amyrin (1), β-amyrin acetate (3), lupeol (5), 
β-sitosterol glucoside (6), rutin (19), 
naringenin (32), psoralen (132), quercetin 
(133), morin (134) 
emodin (135), D-mannitol (136), cinnamic 
acid (137), caffeic acid (138), lactose (139), 
sucrose (140), betulinic acid (141), platanic 
acid (142), stigmasterol (143), 
benjaminamide (144) 
Simo et al., 2008; 
Dafalla, 2002 
 
Number in brackets indicates the number of the structure. 
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H
RO
 
R: H, β-amyrin (1)  
R: Ac, β-amyrin acetate (2) 
H
OH
 
α-amyrin (3) 
 
H
OH
H
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OH
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Sitosterol glucoside (6) 
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+
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O-Rhamnoside
OH
 
Rutin (19) 
H
OH
 
24-methylenecycloartanol (20) 
OH3CO
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OCH3
OCH3
 
5,7,3’,4’,5’-pentamethoxyflavone (21) 
OH3CO
OCH3 O
OCH3
R2
R1
H3CO
 
R1+R2  OCH2O; 5,6,7,5'-tetramethoxy-3',4'-methylenedioxyflavone (22) 
R1=R2 = OCH3; 5,6,7,3',4',5'-hexamethoxyflavone (23) 
R1= OCH3, R2= OCH2CH=CH2 ; 5,6,7,3',5'-pentamethoxy-4'-(prenyloxyflavone) (24) 
O
OCH3
O O 
 
Bergapten (25) 
OH  
β-sitosterol (26) 
24 
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OH
OH
 
11α-hydroxy-β-amyrin (27) 
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O
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Scopoletin (28) 
 
O
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R1=R2= OCH3; 7,4’-dimethoxy-5-
hydroxyisoflavone (29) 
R1=R2= OH; genistein (30) 
 
O
OOH
OH
OH
OH
 
5,7,2’,5’-tetrahydoxyflavanone (31) 
 
O
OOH
OH
R'
R
 
R = H; R' = OH, Naringenin (32) 
R = OH; R' = OCH3, Hesperitin (33)  
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apigenin 6-C-α-L-rhamnopyranosyl-(1—
2)-β—D-glucopyranoside (43) 
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O
O
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OH
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OH
OH
CH3
OH
 
kaempferol 3-O-α-L-rhamnopyranosyl 
(1—6)-β-D- glucopyranoside (44) 
O
O
O
O
O
O
OH
OH
OH
OH
OH
OH
OH
OH
CH3
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kaempferol 3-O-α-L-rhamnopyranosyl 
(1—6)-β-D-galactopyranoside (45) 
O
O
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O
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Demethyl-meliternin (46) 
O
OOCH3
H3CO
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Scutellarein tetramethyl ether (47) 
 
O
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Quercetagetin-3,6,7,3',4'-pentmethyl 
ether (48) 
 
O
OOCH3
H3CO
OCH3
OCH3
OCH3
OCH3
 
Myricetin hexamethyl ether (49) 
